WEGOVY is an injectable prescription medicine: to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
These medications were initially developed to control blood sugar levels in individuals with type 2 diabetes along with a healthy diet and regular physical activity
Read Time: 11 min read Key Takeaways Litigation status: Lawsuits involving Ozempic and other GLP-1 drugs have been grouped together in two separate multidistrict litigations (MDL), helping to expedite the legal process
We wrote more about the science of how GLP-1 works in weight loss, here: GLP-1 for Weight Loss
Introducing three peptides simultaneously makes it impossible to identify which one caused a side effect
Patient education resources from manufacturers, medical societies, and specialized clinics teach proper injection technique, side-effect management, and realistic weight-loss timelines